Evidence map›Paper›PMID 34988372›Full record

ReviewEgyptian journal of neurosurgery2021

Neurogenic pulmonary edema in subarachnoid hemorrhage: relevant clinical concepts.

Ivan David Lozada-Martínez, María Manuela Rodríguez-Gutiérrez, Jenny Ospina-Rios, Michael Gregorio Ortega-Sierra, Mauro Antonio González-Herazo, Lina Marcela Ortiz-Roncallo, Rafael Martínez-Imbett, Andrés Elías Llamas-Nieves, Tariq Janjua, Luis Rafael Moscote-Salazar

Open access · diamondAbstract readReview
In one paragraph

Review in Egyptian journal of neurosurgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ivan David Lozada-MartínezMedical and Surgical Research Center, School of Medicine, University of Cartagena, Cartagena, Colombia.ORCID 0000-0002-1960-7334
María Manuela Rodríguez-GutiérrezDepartment of Medicine, Fundación Universitaria Visión de Las Americas, Pereira, Colombia.
Jenny Ospina-RiosDepartment of Medicine, Fundación Universitaria Visión de Las Americas, Pereira, Colombia.
Michael Gregorio Ortega-SierraMedical and Surgical Research Center, School of Medicine, Corporación Universitaria Rafael Nuñez, Cartagena, Colombia.
Mauro Antonio González-HerazoSchool of Medicine, Universidad de Cartagena, Cartagena, Colombia.
Lina Marcela Ortiz-RoncalloSchool of Medicine, Universidad de La Sabana, Bogotá, Colombia.
Rafael Martínez-ImbettSchool of Medicine, Universidad del Norte, Barranquilla, Colombia.
Andrés Elías Llamas-NievesMedical and Surgical Research Center, School of Medicine, University of Cartagena, Cartagena, Colombia.
Tariq JanjuaDepartment of Intensive Care, Regions Hospital, Saint Paul, MN USA.
Luis Rafael Moscote-SalazarMedical and Surgical Research Center, School of Medicine, University of Cartagena, Cartagena, Colombia.
University of Cartagena · COFundación Universitaria Autónoma De Las Américas · COCorporación Universitaria Rafael Nuñez · CORegions Hospital · USUniversidad de La Sabana · COUniversidad del Norte · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubarachnoid hemorrhage (SAH) continues to be a condition that carries high rates of morbidity, mortality, and disability around the world. One of its complications is neurogenic pulmonary edema (NPE), which is mainly caused by sympathetic hyperactivity. Due to the complexity of the pathophysiological process and the unspecificity of the clinical presentation, it is little known by general practitioners, medical students and other health care workers not directly related to the neurological part, making the management of this chaotic condition difficult. This review aims to present recent evidence on clinical concepts relevant to the identification and management of NPE secondary to SAH. MAIN BODY OF THE ABSTRACT: NPE is defined as a syndrome of acute onset following significant central nervous system (CNS) injury. Its etiology has been proposed to stem from the release of catecholamines that produce cardiopulmonary dysfunction, with this syndrome being associated with spinal cord injury, cerebrovascular disorders, traumatic brain injury, status epilepticus, and meningitis. NPE has long been considered a rare event; but it may occur more frequently, mainly in patients with SAH. There are two clinical presentations of NPE: the early form develops in the first hours/minutes after injury, while the late form presents 12-24 h after neurological injury. Clinical manifestations consist of non-specific signs of respiratory distress: dyspnea, tachypnea, hypoxia, pink expectoration, crackles on auscultation, which usually resolve within 24-48 h in 50% of patients. Unfortunately, there are no tools to make the specific diagnosis, so the diagnosis is by exclusion. The therapeutic approach consists of two interventions: treatment of the underlying neurological injury to reduce intracranial pressure and control sympathetic hyperactivity related to the lung injury, and supportive treatment for pulmonary edema. SHORT

conclusionSAH is a severe condition that represents a risk to the life of the affected patient due to the possible complications that may develop. NPE is one of these complications, which due to the common manifestation of a respiratory syndrome, does not allow early and accurate diagnosis, being a diagnosis of exclusion. Therefore, in any case of CNS lesion with pulmonary involvement, NPE should be suspected immediately.

Indexed as

DiagnosisLung injuryNeurogenic inflammationPulmonary edemaSubarachnoid hemorrhageTreatments

Identifiers

PMID34988372
PMCPMC8590876
OpenAlexW3211835671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.